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The “graying of the globe” is a common mantra to describe the ever-growing segment of the world’s population who are considered old or elder. This phenomenon can be attributed in part to better control of chronic, noncommunicable illnesses associated with aging, such as cancer or cardiovascular disease. However, despite the aging of society as a whole, the definition of chronic kidney dis​ease (CKD), which disproportionately affects elders, has not been altered for almost 2 de​cades. It still uses the same absolute, non-​age-adapted threshold of glomerular filtration rate (GFR), most often estimated from serum creatinine (eGFR), for defining the existence of CKD in the absence of other biomarkers of kidney injury (such as proteinuria, abnormal imaging, or renal pathologic findings).\h Why is this an important issue? Why should this threshold be adapted to age? These questions, which have been asked and discussed repeat​edly over many years, are the subject of this debate.
A threshold of GFR <60 ml/min per m2 was initially chosen as the dividing point for defining CKD in an adult of any age (or sex) so long as this criterion was met persistently over at least 3 months of observation.\h Importantly, this criterion could be applied to subjects without any other mani​festations of kidney injury, such as protein​uria or abnormal imaging. Later iterations of this guideline (such as the Kidney Disease: Improving Global Outcomes [KDIGO] Clin​ical Practice Guidelines, 2013) preserved this threshold for CKD, but divided the strata of GFR into 6 distinct categories (G1, G2, G3A, G3B, G4, G5) using 15 ml/min per m2 increments and formally added albuminuria thresholds according to urinary albumin to creatinine ratios (A1, <30 mg/gm; A2, 30-300 mg/gm; A3, >300 mg/gm).\h This simple schema was a boon to epidemiologists who quickly ascertained that CKD, so defined, was common in the general population of adults and was associated with a variety of adverse outcomes (such as ESKD, cardiovas​cular disease, and acute kidney injury).\h  Un​fortunately, many of the described associations were based on a single assess​ment of GFR, which generated a surfeit of “false-positive” diagnoses of CKD.\h But what is most germane to the present discussion is that the frequency of CKD, as so defined by a single absolute threshold of GFR, dramatically increases with aging; this increase, in part, depends on the equation and method used to estimate GFR.\h 
These phenomena prompted a reassess​ment of the nature of the change in GFR that occurs with normal healthy aging. As a consequence of detailed study of kidney morphology and function among very healthy, normal, kidney transplant donors of widely varying age (20 to 75+ years), undergoing pretransplant kidney imaging anatomy and functional assessment as well as preimplanta​tion kidney biopsies, we now know a great deal more about normal kidney senescence and can apply this knowledge to developing better definitions of CKD that are adapted to the physiological changes in the kidney that occur in normal human aging.\h 

Table 1. A comparison between the anatomic and functional changes in the kidneys observed with healthy, normal aging and bona fide CKD
Parameter	Healthy aging	CKD
Structural	
       Glomeruli	Ischemic glomeruli progress to global sclerosis and eventually atrophy/disappear.Glomerulosclerosis occurs predominately in the superficial cortex.No glomerular enlargement	Glomerulosclerosis may be segmental or global and via ischemic or solidification pathways.Glomerulosclerosis occurs diffusely throughout cortex.Glomerular enlargement often occurs during early stages.
Tubules/interstitium	Minimal interstitial fibrosis and tubular atrophy despite substantial nephron loss	Interstitial fibrosis and tubular atrophy are usually present and reflect severity of nephron loss.
Arteries	Arteriosclerosis is often evident.	Primarily affects glomeruli, tubules, interstitium, and sometimes arteries
Functional	
      Total GFR	Declines	Declines
      Nephron number	Declines	Declines
      Single-nephron GFR	Stable	Often increases
      Albuminuria	Absent	Often present
CKD, chronic kidney disease; GFR, glomerular filtration rate.

We now know that the average measured GFR in 20- to 30-year-old normal healthy hu​man adults is about 107 ml/min per 1.73 m2.\h  We also now know that the GFR declines by about 6 to 7 ml/min per 1.73 m2 per decade beginning sometime after age 35 to 40 years, due to a process of progressive nephron loss due to focal and global glomerulosclerosis preferentially affecting the superficial cortex, unaccompanied by compensatory glomerular enlargement or hyperfiltration (increased single nephron GFR [snGFR]) in the remaining nonsclerosed glomeruli.\h ,\h  This differs dramatically from nephron loss accompanying early CKD, which is more diffuse across the cortical depth and often associates with glomerular enlargement and increases in snGFR in residual nephrons.\h  Over 50 years, about one-half of the original nephron popu​lation are lost.\h  
Any glomerular hypertrophy or focal and segmental glomerulosclerosis seen in the kidney can largely be attributed not to aging per se but to comorbidities of aging (such as obesity or diabetes).\h  Abnormal albuminuria is not a phenomenon connected to normal, healthy aging of the kidney, but it is almost always a manifestation of a comorbid condi​tion. The average measured GFRs of heathy otherwise normal 65- and 75-year-old persons are about 83 and 76 ml/min per 1.73 m2. Correspondingly, the lower limits of normal (2.5th percentile for a measured GFR) are 55 and 49 ml/min per 1.73 m2 in 65- or 75-year- old persons, respectively.\h  A comparison of the key features of the normal health aging kidney and bona fide CKD are provided in \h .
This analysis of the physiology of healthy aging immediately draws attention to the category of CKD, characterized as G3A/A1 with a GFR of 45 to 59 ml/min per 1.73 m2 and a urinary albumin-to-creatinine ratio <30 mg/ gm. This category of CKD is the most common one observed in older adults. If one accepts the notion that a GFR between 45 and 59 ml/min per 1.73 m2 not accompanied by abnormal albuminuria in an otherwise healthy appearing subject is compatible with physiological aging, how can one not also accept that this is also not a disease (CKD)?
A counterargument to this position is that “disease” cannot solely be defined as a statis​tical departure from a normal “nondisease” frame of reference, but rather the connection with a predilection for adverse events, including the shortening of life expectancy via augmented mortality risk, needs to be taken into account. Indeed, the KDIGO 2013 schema incorporates prognosis (risk of adverse events, including death) into its matrix of definitions of CKD (also called “heat maps”).\h This argument carries substantial weight as it is based on patient-centered outcomes. However, careful inspection and rigorous analysis of data bearing on this issue raise doubts and con​troversy. For example, the seminal observation of Go et al.,11\h that the increased risk of mor​tality and hospitalization (mostly for cardio​vascular reasons) is associated with declining GFR, actually demonstrated little additional risk in subjects with an eGFR of 45 to 59 ml/ min per 1.73 m2 when the assessment of eGFR was repeated more than once. Furthermore, when comparisons of risk from epidemiolog​ical data involving aging and GFR are made, the choice of the reference group is critical.\h  Indeed, in subjects older than 65 years of age and an eGFR of 45 to 59 ml/min per m2, the risk of excess mortality is trivial when compared with that of a reference group of similarly aged persons with an eGFR of 75 to 89 ml/min per 1.73 m2 (an average eGFR for this older age category) and does not in​crease to significant levels until the eGFR is <45 ml/min per 1.73 m2.\h  In young per​sons, the enhanced risk of mortality begins to rise when eGFR is <75 ml/min per 1.73 m2 using a reference eGFR of ≥ 105 ml/min per m2.\h  Thus, the epidemiologic data asso​ciating eGFR with adverse events provide strong support for age-adapted thresholds of eGFR when utilizing a prognosis-based defi​nition of CKD.
Correction of the flaws inherent to existing means of identifying CKD has and will continue to be resisted. On the one hand, little doubt exists that a uniform classification and nomenclature for CKD has enhanced the vis​ibility of the disease in public, professional, and scientific spheres. The schema utilized has also galvanized an enormous outpouring of epidemiological, observational studies of CKD, so defined. The knowledge base in CKD has correspondingly grown enormously. But the trade-offs have been the overdiagnosis of CKD in older and elder adults, underdiagnosis of CKD in youth, and overestimates of the burden of CKD in the general population, especially where growing older is more common.\h ,\h 
Much can be done to correct this situation by the incorporation of age-adaption for the thresholds used to define CKD by eGFR alone. Specifically, the eGFR thresholds for defining CKD could be adapted to <75 m/min per 1.73 m2 in youth, <60 ml/min per 1.73 m2 for middle age, and <45 ml/min per 1.73 m2 for older adults.\h  This is simple, but disadvan​taged by the “birthday paradox,” which is the cure of CKD by reaching the specific age cat​egories. Using percentiles derived from values of mGFR or eGFR according to age in healthy living donors is also an option, but this data​base is bereft of values for subjects $80 years old.\h  Standard deviation scoring systems commonly used in pediatric practice and osteoporosis diagnosis are also attractive alter- natives.\h  The development of a series of age category-specific heat maps for subjects <20 to 44 years, 45-64 years, and $65 years would be relatively simple and allow for an age-adapted diagnosis of CKD that incorporates both the threshold of mGFR or eGFR and the associated prognosis at differing levels of proteinuria, providing that the “chronicity criterion” is maintained.\h 
If any of these age-adapted definitions of CKD were adopted, the prevalence of the diagnosed CKD in the general population would likely fall, and markedly so in some situations.\h This would help to avoid un​necessary anxiety, excessive referrals to spe​cialists, and useless testing. But the avoidance of an improper diagnostic label of CKD does not mean that otherwise healthy subjects with a GFR in the lower percentiles according to age should not receive appropriate precau​tionary advice regarding the use of potentially nephrotoxic drugs or dosing adjustments of water-soluble drugs cleared by the kidney. Certainly, some older patients might have less “renal reserve,” placing them at higher risk for acute kidney injury in the setting of an illness. What we argue for is a tacit recognition of the defects inherent in a non-age-adapted schema using an absolute GFR criterion for the diagnosis of CKD. In our view, this should and must be corrected going forward.
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